Connecting you to content on EBSCOhost

Works by Figg, W. Douglas

Results: 6

1

Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.

Published in:

2016

By:

Noonan, Anne M.;
Bunch, Kristen P.;
Chen, Jin‐Qiu;
Herrmann, Michelle A.;
Lee, Jung‐Min;
Kohn, Elise C.;
O'Sullivan, Ciara C.;
Jordan, Elizabeth;
Houston, Nicole;
Takebe, Naoko;
Kinders, Robert J.;
Cao, Liang;
Peer, Cody J.;
Figg, W. Douglas;
Annunziata, Christina M.;
Chen, Jin-Qiu;
Lee, Jung-Min

Publication type:

journal article

2

Suramin administration is associated with a decrease in serum calcium levels.

Published in:

World Journal of Urology, 2000, v. 18, n. 6, p. 388, doi. 10.1007/s003459900095

By:

Walther, McClellan M.;
Rehak, Nadja N.;
Venzon, David;
Myers, Charles E.;
Linehan, W. Marston;
Figg, W. Douglas

Publication type:

Article

3

Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.

Published in:

2012

By:

Bose P;
Perkins EB;
Honeycut C;
Wellons MD;
Stefan T;
Jacobberger JW;
Kontopodis E;
Beumer JH;
Egorin MJ;
Imamura CK;
Douglas Figg W Sr;
Karp JE;
Koc ON;
Cooper BW;
Luger SM;
Colevas AD;
Roberts JD;
Grant S;
Bose, Prithviraj;
Perkins, Edward B

Publication type:

journal article

4

Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl hematological malignancies.

Published in:

2012

By:

Bose, Prithviraj;
Perkins, Edward;
Honeycut, Connie;
Wellons, Martha;
Stefan, Tammy;
Jacobberger, James;
Kontopodis, Emmanouil;
Beumer, Jan;
Egorin, Merrill;
Imamura, Chiyo;
Douglas Figg, W.;
Karp, Judith;
Koc, Omer;
Cooper, Brenda;
Luger, Selina;
Colevas, A.;
Roberts, John;
Grant, Steven

Publication type:

Report

5

Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor-Negative Breast Cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 9, p. 632, doi. 10.1093/jnci/dji111

By:

Palmieri, Diane;
Halverson, Douglas O.;
Ouatas, Taoufik;
Horak, Christine E.;
Salerno, Massimiliano;
Johnson, Jennifer;
Figg, W. Douglas;
Hollingshead, Melinda;
Hursting, Stephen;
Berrigan, David;
Steinberg, Seth M.;
Merino, Maria J.;
Steeg, Patricia S.

Publication type:

Article

6

Distinct uptake and elimination profiles for trastuzumab, human IgG, and biocytin-TMR in experimental HER2+ brain metastases of breast cancer.

Published in:

Neuro-Oncology, 2024, v. 26, n. 6, p. 1067, doi. 10.1093/neuonc/noae025

By:

Silvestri, Vanesa L;
Tran, Andy D;
Chung, Monika;
Chung, Natalie;
Gril, Brunilde;
Robinson, Christina;
Difilippantonio, Simone;
Wei, Debbie;
Kruhlak, Michael J;
Peer, Cody J;
Figg, W Douglas;
Khan, Imran;
Steeg, Patricia S

Publication type:

Article